"Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis." Neurology - Neuroimmunology Neuroinflammation
9.6
(2022):
e200019.
Web. 28 Sept2023.
Advertisement